Whatman® anion exchange cellulose



pkg of 500 g


Whatman 4057-050
Whatman Article No. 28419498 (US reference)

Looking for similar products? Visit Product Comparison Guide

General description

The DE weak (charge dependent on pH) anion exchangers are based on the diethylaminoethyl (DEAE) tertiary amine functional group. QA52 is a strong (charge independent of pH) anion exchange medium, containing quaternary amine groups.

DE23 dry fibrous DEAE cellulose - Allows fast flow rates especially after fines removal; suitable for negatively charged biopolymers.

DE32 dry microgranular DEAE cellulose - Similar performance characteristics after precycling as DE52.

DE52 preswollen microgranular DEAE cellulose - Probably the most widely used DEAE cellulose in the world; used for biopolymers with low to high negative charges; exhibits excellent resolution with good flow rates.

DE53 preswollen microgranular DEAE cellulose - Partially quaternized DEAE anion exchanger, highly substituted and with higher capacity than DE52; can be used in series with DE52 media.

QA52 preswollen microgranular QA cellulose - A strongly basic, quaternary amine-bearing anion exchange medium, moderately substituted, with high protein capacity. Fully ionized, bears constant charge under all pH conditions; excellent for high pH applications.

Other Notes

Field of Use : For internal research use only. Products are not intended for diagnostic use or resale.

Legal Information

Whatman is a registered trademark of Cytiva


NONH for all modes of transport

WGK Germany


Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis

Certificate of Origin

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.